[e-drug] R&D costs for drugs (3)

[Norman Nyazema <nznyazema@yahoo.com>]

E-DRUG: R&D costs for drugs (3)
-------------------------------

I can see and understand the arguement to relook at the different stages of
drug development and see where costs, normally passed to the consumer, can
be cut. I do not, however, agree that Phase III should be that stage of R&D.
This is an important stage where a large number of patients in a setting
close to the intended clinical use are required. What would be the use of
picking up problems when the product is already in general consumption. I do
agree though that PMS should be agressively promoted.

Every stage of drug development needs a close relook..

Norman Z. Nyazema
Zimbabwe
nznyazema@yahoo.com

--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug